Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2006 | 03-2006 | 12-2005 | 09-2005 | 06-2005 | |
| Gross Profit | 2,280 | 2,110 | 1,620 | 2,370 | 2,000 |
| Operating Expenses | 6,550 | 6,260 | 6,260 | 5,700 | 5,160 |
| Operating Income | -6,550 | -6,260 | -6,260 | -5,700 | -5,160 |
| Pre-tax Income | -6,550 | -6,260 | -6,260 | -5,700 | -5,160 |
| Net Income Continuous | -6,550 | -6,260 | -6,260 | -5,700 | -5,160 |
| Net Income | $-6,550 | $-6,260 | $-6,260 | $-5,700 | $-5,160 |
| EBITDA(a) | $-4,820 | $-4,920 | $-5,580 | $-4,410 | $-3,740 |